Cargando…

Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis

BACKGROUND. Nonalcoholic steatohepatitis (NASH) is a severe immune-mediated stage of nonalcoholic fatty liver disease that is rapidly becoming the most common etiology requiring liver transplantation (LT), with Hispanics bearing a disproportionate burden. This study aimed to uncover the underlying i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa, Rebecca A., Terry, Allyson Q., Ito, Takahiro, Naini, Bita V., Zheng, Ying, Pickering, Harry, Nevarez-Mejia, Jessica, Busuttil, Ronald W., Gjertson, David W., Kupiec-Weglinski, Jerzy W., Reed, Elaine F., Kaldas, Fady M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593264/
https://www.ncbi.nlm.nih.gov/pubmed/37876917
http://dx.doi.org/10.1097/TXD.0000000000001550
_version_ 1785124415871123456
author Sosa, Rebecca A.
Terry, Allyson Q.
Ito, Takahiro
Naini, Bita V.
Zheng, Ying
Pickering, Harry
Nevarez-Mejia, Jessica
Busuttil, Ronald W.
Gjertson, David W.
Kupiec-Weglinski, Jerzy W.
Reed, Elaine F.
Kaldas, Fady M.
author_facet Sosa, Rebecca A.
Terry, Allyson Q.
Ito, Takahiro
Naini, Bita V.
Zheng, Ying
Pickering, Harry
Nevarez-Mejia, Jessica
Busuttil, Ronald W.
Gjertson, David W.
Kupiec-Weglinski, Jerzy W.
Reed, Elaine F.
Kaldas, Fady M.
author_sort Sosa, Rebecca A.
collection PubMed
description BACKGROUND. Nonalcoholic steatohepatitis (NASH) is a severe immune-mediated stage of nonalcoholic fatty liver disease that is rapidly becoming the most common etiology requiring liver transplantation (LT), with Hispanics bearing a disproportionate burden. This study aimed to uncover the underlying immune mechanisms of the disparities experienced by Hispanic patients undergoing LT for NASH. METHODS. We enrolled 164 LT recipients in our institutional review board-approved study, 33 of whom presented with NASH as the primary etiology of LT (20%), with 16 self-reported as Hispanic (48%). We investigated the histopathology of prereperfusion and postreperfusion biopsies, clinical liver function tests, longitudinal soluble cytokines via 38-plex Luminex, and immune cell phenotypes generated by prereperfusion and postreperfusion blood using 14-color flow cytometry and enzyme-linked immunosorbent assay. RESULTS. Hispanic LT recipients transplanted for NASH were disproportionately female (81%) and disproportionately suffered poor outcomes in the first year posttransplant, including rejection (26%) and death (38%). Clinically, we observed increased pro-inflammatory and apoptotic histopathological features in biopsies, increased AST/international normalized ratio early posttransplantation, and a higher incidence of presensitization to mismatched HLA antigens expressed by the donor allograft. Experimental investigations revealed that blood from female Hispanic NASH patients showed significantly increased levels of leukocyte-attracting chemokines, innate-to-adaptive switching cytokines and growth factors, HMGB1 release, and TLR4/TLR8/TLR9/NOD1 activation, and produced a pro-inflammatory, pro-apoptotic macrophage phenotype with reduced CD14/CD68/CD66a/TIM-3 and increased CD16/CD11b/HLA-DR/CD80. CONCLUSIONS. A personalized approach to reducing immunological risk factors is urgently needed for this endotype in Hispanics with NASH requiring LT, particularly in females.
format Online
Article
Text
id pubmed-10593264
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105932642023-10-24 Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis Sosa, Rebecca A. Terry, Allyson Q. Ito, Takahiro Naini, Bita V. Zheng, Ying Pickering, Harry Nevarez-Mejia, Jessica Busuttil, Ronald W. Gjertson, David W. Kupiec-Weglinski, Jerzy W. Reed, Elaine F. Kaldas, Fady M. Transplant Direct Liver Transplantation BACKGROUND. Nonalcoholic steatohepatitis (NASH) is a severe immune-mediated stage of nonalcoholic fatty liver disease that is rapidly becoming the most common etiology requiring liver transplantation (LT), with Hispanics bearing a disproportionate burden. This study aimed to uncover the underlying immune mechanisms of the disparities experienced by Hispanic patients undergoing LT for NASH. METHODS. We enrolled 164 LT recipients in our institutional review board-approved study, 33 of whom presented with NASH as the primary etiology of LT (20%), with 16 self-reported as Hispanic (48%). We investigated the histopathology of prereperfusion and postreperfusion biopsies, clinical liver function tests, longitudinal soluble cytokines via 38-plex Luminex, and immune cell phenotypes generated by prereperfusion and postreperfusion blood using 14-color flow cytometry and enzyme-linked immunosorbent assay. RESULTS. Hispanic LT recipients transplanted for NASH were disproportionately female (81%) and disproportionately suffered poor outcomes in the first year posttransplant, including rejection (26%) and death (38%). Clinically, we observed increased pro-inflammatory and apoptotic histopathological features in biopsies, increased AST/international normalized ratio early posttransplantation, and a higher incidence of presensitization to mismatched HLA antigens expressed by the donor allograft. Experimental investigations revealed that blood from female Hispanic NASH patients showed significantly increased levels of leukocyte-attracting chemokines, innate-to-adaptive switching cytokines and growth factors, HMGB1 release, and TLR4/TLR8/TLR9/NOD1 activation, and produced a pro-inflammatory, pro-apoptotic macrophage phenotype with reduced CD14/CD68/CD66a/TIM-3 and increased CD16/CD11b/HLA-DR/CD80. CONCLUSIONS. A personalized approach to reducing immunological risk factors is urgently needed for this endotype in Hispanics with NASH requiring LT, particularly in females. Lippincott Williams & Wilkins 2023-10-20 /pmc/articles/PMC10593264/ /pubmed/37876917 http://dx.doi.org/10.1097/TXD.0000000000001550 Text en Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Liver Transplantation
Sosa, Rebecca A.
Terry, Allyson Q.
Ito, Takahiro
Naini, Bita V.
Zheng, Ying
Pickering, Harry
Nevarez-Mejia, Jessica
Busuttil, Ronald W.
Gjertson, David W.
Kupiec-Weglinski, Jerzy W.
Reed, Elaine F.
Kaldas, Fady M.
Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title_full Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title_fullStr Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title_full_unstemmed Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title_short Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
title_sort immune features of disparate liver transplant outcomes in female hispanics with nonalcoholic steatohepatitis
topic Liver Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593264/
https://www.ncbi.nlm.nih.gov/pubmed/37876917
http://dx.doi.org/10.1097/TXD.0000000000001550
work_keys_str_mv AT sosarebeccaa immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT terryallysonq immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT itotakahiro immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT nainibitav immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT zhengying immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT pickeringharry immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT nevarezmejiajessica immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT busuttilronaldw immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT gjertsondavidw immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT kupiecweglinskijerzyw immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT reedelainef immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis
AT kaldasfadym immunefeaturesofdisparatelivertransplantoutcomesinfemalehispanicswithnonalcoholicsteatohepatitis